Indo Us Bio-Tech Limited - Company Profile

It is a agriculture public limited company based in Ahmedabad, Gujarat, India, established in 2004.
2004 Ahmedabad, Gujarat, India Active
Last Updated:
Access Report
About Indo Us Bio-Tech Limited

Indo Us Bio-Tech Limited, a active public limited company, was established on 04 February 2004 in Ahmedabad, Gujarat, India. Engaging in seed production & distribution within the agriculture, forestry, fishing sector, it holds CIN: L01122GJ2004PLC043550. Registered under ROC Roc Ahmedabad. it is listed on BSE: 541304. It has an authorized capital of ₹32.00 Cr and a paid-up capital of ₹20.05 Cr.

Formerly known as Pellucid Bio-Tech Private Limited, Indo Us Bio-Tech Private Limited. It upholds a compliant status. In 2023, it reported revenue of ₹61.77 Cr and a net worth of ₹54.50 Cr. Employing 29 professional, Its leadership includes Shilpa Chetanbhai Thumar (Director), Nehaben Sachinbhai Patel (Director), Priyanka Jagdishbhai Ajudia (Director). Past directors included Dhiren Vithaldas Savalia, Gordhanbhai Karshanbhai Gangani, Shilpa Chetanbhai Thumar. It holds ₹28.79 Cr open charges and ₹17.46 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 309, Shanti Mall, Satadhar Char Rasta Opp. Navrang Tower, Sola Road, Ahmedabad, Gujarat, 380061.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    L01122GJ2004PLC043550

  • Registration Number

    043550

  • Incorporation Date

    04 February 2004

  • Authorized Capital

    ₹32.00 Cr

  • Paid-Up Capital

    ₹20.05 Cr

  • ROC Code

    Roc Ahmedabad

  • Listing Status

    Listed (BSE: 541304)

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 32.00 Cr
  • Paid Up Capital ₹ 20.05 Cr
  • Company Age 22 Year, 26 Days
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 28.79 Cr
  • Satisfied Charges ₹ 17.46 Cr
  • Revenue Growth **** 22.95%
  • Profit Growth **** 38.25%
  • Ebitda **** 35.49%
  • Net Worth 40.17%
  • Total Assets **** 25.00%
Company report

Indo Us Bio-Tech Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Indo Us Bio-Tech Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Indo Us Bio-Tech Limited?
Current Directors
Name Designation Appointment Date Status
Shilpa Chetanbhai Thumar Director 05 Aug 2021 Current
Nehaben Sachinbhai Patel Director 05 Aug 2021 Current
Priyanka Jagdishbhai Ajudia Director 23 Nov 2017 Current
Malti Jagdishbhai Ajudia Whole-Time Director 01 Nov 2008 Current
Jagdishkumar Devjibhai Ajudiya Managing Director 04 Feb 2004 Current
Ritaben Nileshbhai Kikani Director 01 Mar 2019 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 05 Dec 2018 Past
Pramod Abcsdd Additional Director 25 Nov 2017 Past
Pramod Abcsdd Additional Director 29 Sep 2021 Past
Pramod Abcsdd Additional Director 29 Sep 2021 Past
Pramod Abcsdd Director 10 Feb 2021 Past
Pramod Abcsdd Additional Director 30 Sep 2020 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Indo Us Bio-Tech.

Indo Us Bio-Tech Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 22.95% increase. The company also saw a substantial improvement in profitability, with a 38.25% increase in profit. The company's net worth Soared by an impressive increase of 40.17%.

Indo Us Bio-Tech revenue growth over time
Indo Us Bio-Tech profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 22.95%
*******
*******
*******
*******
Revenue from Operations
*******
 23.36%
*******
*******
*******
*******
Total Assets
*******
 25.00%
*******
*******
*******
*******
Profit or Loss
*******
 38.25%
*******
*******
*******
*******
Net Worth
*******
 40.17%
*******
*******
*******
*******
EBITDA
*******
 35.49%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Indo Us Bio-Tech?

In 2023, Indo Us Bio-Tech had a promoter holding of 70.17% and a public holding of 29.83%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹287,850,000.00

Satisfied Charges

₹174,600,000.00

Charges Breakdown by Lending Institutions
  • Axis Bank Limited : 28.68 Cr
  • Others : 0.11 Cr
Latest Charge Details
Date Lender Amount Status
24 Jun 2025 Axis Bank Limited ₹25.23 Cr Open
18 Apr 2023 Axis Bank Limited ₹2.00 Cr Open
20 Sep 2022 Axis Bank Limited ₹1.45 Cr Open
16 Jun 2022 Others ₹1.05 M Open
09 Nov 2019 Others ₹11.41 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Indo Us Bio-Tech?

Indo Us Bio-Tech has a workforce of 29 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Indo Us Bio-Tech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Indo Us Bio-Tech's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Indo Us Bio-Tech
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Indo Us Bio-Tech Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.

  • Charges

    The activity A charge with Axis Bank Limited amounted to Rs. 25.23 Cr with Charge ID 101127905 was registered on 24 Jun 2025. was completed.

  • Balance Sheet

    Progress on Indo Us Bio-Tech Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad. was documented.

  • Charges

    A charge with Axis Bank Limited amounted to Rs. 2.00 Cr with Charge ID 100716412 was registered on 18 Apr 2023. was recorded as a recent event.

  • Charges

    A charge registered on 09 Nov 2019 via Charge ID 100299902 with Others was fully satisfied on 10 Nov 2022. was recorded as a recent event.

  • Charges

    The activity A charge registered on 21 Feb 2012 via Charge ID 10342992 with Dena Bank was fully satisfied on 10 Nov 2022. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Indo Us Bio-Tech Limited?

The CIN of Indo Us Bio-Tech Limited is L01122GJ2004PLC043550.

Where is Indo Us Bio-Tech Limited headquartered?

Indo Us Bio-Tech Limited is headquartered at 309, Shanti Mall, Satadhar Char Rasta Opp. Navrang Tower, Sola Road, Ahmedabad, Gujarat, 380061.

When was Indo Us Bio-Tech Limited incorporated?

Indo Us Bio-Tech Limited was incorporated on 04 February 2004.

Who are the current directors of Indo Us Bio-Tech Limited?

The current directors of Indo Us Bio-Tech Limited are

What is the primary industry of Indo Us Bio-Tech Limited?

The primary industry of Indo Us Bio-Tech Limited is Agriculture, Forestry, Fishing.

Is Indo Us Bio-Tech Limited a listed company?

Indo Us Bio-Tech Limited is listed. It is listed on BSE: 541304.

What is the capital structure of Indo Us Bio-Tech Limited?

The authorized capital of Indo Us Bio-Tech Limited is ₹32.00 Cr, and the paid-up capital is ₹20.05 Cr.

What is the compliance status of Indo Us Bio-Tech Limited?

The compliance status of Indo Us Bio-Tech Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available